Related Experiment Video
Updated: Oct 10, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Theoretical study and application of 2-phenyl-1,3,4-thiadiazole derivatives with optical and inhibitory activity
Chun Zhang1, Yi-Tao Sun1, Li-Xin Gao1,2
1School of Pharmaceutical Sciences, Jiangnan University, Wuxi, 214122, China. wwenlong2011@163.com.
Abstract:
Src homology-2 domain-containing protein tyrosine phosphatase 1 (SHP1) is mainly restricted to hematopoietic and epithelial cells and widely accepted as a convergent node for oncogenic cell-signaling cascades. The development of efficient methods for rapidly tracing and inhibiting the SHP1 activity in complex biological systems is of considerable significance for advancing the integration of diagnosis and treatment of the related disease. With this aim, we designed and synthesized five 2-phenyl-1,3,4-thiadiazole derivatives (PT2, PT5, PT8, PT9 and PT10) here based on the reported SHP1 inhibitors (PT1, PT3, PT4, PT6 and PT7). The photophysical properties and inhibitory activities of these 2-phenyl-1,3,4-thiadiazole derivatives (PT1-PT10) against SHP1 were thoroughly studied from the theoretical simulation and experimental application aspects. The representative compound PT10 exhibited a larger quantum yield than the other molecules because of the smaller geometric relaxation and reorganization energy of the excited state, which was consistent with the results from the fluorescence experiments in organic solvents. In addition, PT10 showed a selective fluorescence response for SHP1 activity and low cytotoxicity in HeLa cells. Lastly, it indicated the potential application in two-photon cell fluorescence imaging in the future according to the calculated excellent two-photon absorption properties. In this contribution, firstly, we offered the fluorescent and activated molecule PT10 against SHP1, which achieved the integration of visualization and inhibitory activity of SHP1 preliminarily at the enzyme molecular level.
Insights
Researchers developed a fluorescent molecule, PT10, to visualize and inhibit Src homology-2 domain-containing protein tyrosine phosphatase 1 (SHP1). This advancement aids in understanding SHP1
Area of Science:
- Biochemistry
- Chemical Biology
- Molecular Imaging
Background:
- Src homology-2 domain-containing protein tyrosine phosphatase 1 (SHP1) is a key regulator in oncogenic signaling pathways.
- Targeting SHP1 is crucial for developing novel cancer therapies.
- Efficient methods for SHP1 activity tracing and inhibition are needed.
Purpose of the Study:
- To design and synthesize novel 2-phenyl-1,3,4-thiadiazole derivatives as SHP1 inhibitors.
- To investigate the photophysical properties and inhibitory activities of these compounds.
- To develop a fluorescent probe for SHP1 activity visualization and inhibition.
Main Methods:
- Synthesis of ten 2-phenyl-1,3,4-thiadiazole derivatives (PT1-PT10).
- Theoretical simulations and experimental studies of photophysical properties and SHP1 inhibitory activity.
- In vitro assays including fluorescence spectroscopy and cytotoxicity tests in HeLa cells.
Main Results:
- Compound PT10 demonstrated superior fluorescence quantum yield due to reduced excited-state relaxation.
- PT10 selectively responded to SHP1 activity with low cytotoxicity.
- Calculated two-photon absorption properties suggest potential for advanced cell imaging.
Conclusions:
- A novel fluorescent inhibitor, PT10, was developed for SHP1.
- PT10 integrates visualization and inhibitory functions at the molecular level.
- This offers a promising tool for SHP1-related disease research and diagnostics.
More Related Videos
08:45Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015